AlzeCure Pharma AB's total assets for Q4 2025 were kr59.04M, a decrease of -11.33% from the previous quarter. DE:AC6 total liabilities were kr26.12M for the fiscal quarter, a 64.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.